Skip to main content

Advertisement

SpringerLink
Log in

Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data

  • Systematic Review
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Purpose

The number of averted deaths due to therapeutic advances in oncology and hematology is substantial and increasing. Survival of critically ill cancer patients has also improved during the last 2 decades. However, these data stem predominantly from unadjusted analyses. The aim of this study was to assess the impact of ICU admission year on short-term survival of critically ill cancer patients, with special attention on those with neutropenia.

Methods

Systematic review and meta-analysis of individual data according to the guidelines of meta-analysis of observational studies in epidemiology.

Datasource

Pubmed and Cochrane databases.

Eligibility criteria

Adult studies published in English between May 2005 and May 2015.

Results

Overall, 7354 patients were included among whom 1666 presented with neutropenia at ICU admission. Median ICU admission year was 2007 (IQR 2004–2010; range 1994–2012) and median number of admissions per year was 693 (IQR 450–1007). Overall mortality was 47.7%. ICU admission year was associated with a progressive decrease in hospital mortality (OR per year 0.94; 95% CI 0.93–0.95). After adjustment for confounders, year of ICU admission was independently associated with hospital mortality (OR for hospital mortality per year: 0.96; 95% CI 0.95–0.97). The association was also seen in patients with neutropenia but not in allogeneic stem cell transplant recipients.

Conclusion

After adjustment for patient characteristics, severity of illness and clustering, hospital mortality decreased steadily over time in critically ill oncology and hematology patients except for allogeneic stem cell transplant recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

DFLST:

Decision to forgo life-sustaining therapy

ICU:

Intensive care unit

HSCT:

Hematopoietic stem cell transplant

OR:

Odds ratio

RRT:

Renal replacement therapy

IQR:

Interquartile range

95% CI:

95% Confidence interval

APACHE:

Acute physiology and chronic health evaluation

SAPS:

Simplified acute physiology score

References

  1. Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386. https://doi.org/10.1002/ijc.29210

    Article  CAS  PubMed  Google Scholar 

  2. GBD 2015 Mortality and Causes of Death Collaborators (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1459–1544. https://doi.org/10.1016/S0140-6736(16)31012-1

    Article  Google Scholar 

  3. Vento S, Cainelli F, Temesgen Z (2008) Lung infections after cancer chemotherapy. Lancet Oncol 9:982–992. https://doi.org/10.1016/S1470-2045(08)70255-9

    Article  PubMed  Google Scholar 

  4. Morgan C, Tillett T, Braybrooke J, Ajithkumar T (2011) Management of uncommon chemotherapy-induced emergencies. Lancet Oncol 12:806–814. https://doi.org/10.1016/S1470-2045(10)70208-4

    Article  PubMed  Google Scholar 

  5. Wanchoo R, Karam S, Uppal NN et al (2017) Adverse renal effects of immune checkpoint inhibitors: a narrative review. Am J Nephrol 45:160–169. https://doi.org/10.1159/000455014

    Article  CAS  PubMed  Google Scholar 

  6. Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360:1131–1135. https://doi.org/10.1016/S0140-6736(02)11199-8

    Article  PubMed  Google Scholar 

  7. Sant M, Minicozzi P, Mounier M et al (2014) Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol 15:931–942. https://doi.org/10.1016/S1470-2045(14)70282-7

    Article  PubMed  Google Scholar 

  8. Verdecchia A, Francisci S, Brenner H et al (2007) Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol 8:784–796. https://doi.org/10.1016/S1470-2045(07)70246-2

    Article  PubMed  Google Scholar 

  9. Azoulay E, Recher C, Alberti C et al (1999) Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 25:1395–1401

    Article  CAS  Google Scholar 

  10. Peigne V, Rusinová K, Karlin L et al (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35:512–518. https://doi.org/10.1007/s00134-008-1320-4

    Article  PubMed  Google Scholar 

  11. Mokart D, Pastores SM, Darmon M (2014) Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 40:1570–1572. https://doi.org/10.1007/s00134-014-3433-2

    Article  PubMed  Google Scholar 

  12. Darmon M, Azoulay E (2009) Critical care management of cancer patients: cause for optimism and need for objectivity. Curr Opin Oncol 21:318–326. https://doi.org/10.1097/CCO.0b013e32832b68b6

    Article  PubMed  Google Scholar 

  13. Shimabukuro-Vornhagen A, Böll B, Kochanek M et al (2016) Critical care of patients with cancer. CA Cancer J Clin 66:496–517. https://doi.org/10.3322/caac.21351

    Article  PubMed  Google Scholar 

  14. Lengliné E, Chevret S, Moreau A-S et al (2015) Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 50:840–845. https://doi.org/10.1038/bmt.2015.55

    Article  PubMed  Google Scholar 

  15. Lueck C, Stadler M, Koenecke C et al (2018) Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med 44:1483–1492. https://doi.org/10.1007/s00134-018-5347-x

    Article  PubMed  Google Scholar 

  16. Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700

    Article  Google Scholar 

  17. Bouteloup M, Perinel S, Bourmaud A et al (2017) Outcomes in adult critically ill cancer patients with and without neutropenia: a systematic review and meta-analysis of the Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH). Oncotarget 8:1860–1870. https://doi.org/10.18632/oncotarget.12165

    Article  PubMed  Google Scholar 

  18. Georges Q, Azoulay E, Mokart D et al (2018) Influence of neutropenia on mortality of critically ill cancer patients: results of a meta-analysis on individual data. Crit Care 22:326. https://doi.org/10.1186/s13054-018-2076-z

    Article  PubMed  PubMed Central  Google Scholar 

  19. Rydenfelt K, Engerström L, Walther S et al (2015) In-hospital vs. 30-day mortality in the critically ill—a 2-year Swedish intensive care cohort analysis. Acta Anaesthesiol Scand 59:846–858. https://doi.org/10.1111/aas.12554

    Article  CAS  PubMed  Google Scholar 

  20. Schneider AG, Lipcsey M, Bailey M et al (2013) Simple translational equations to compare illness severity scores in intensive care trials. J Crit Care 28:885.e1–885.e8. https://doi.org/10.1016/j.jcrc.2013.02.003

    Article  Google Scholar 

  21. Biard L, Labopin M, Chevret S et al (2018) Investigating covariate-by-centre interaction in survival data. Stat Methods Med Res 27:920–932. https://doi.org/10.1177/0962280216647981

    Article  CAS  PubMed  Google Scholar 

  22. Nattino G, Finazzi S, Bertolini G (2014) A new calibration test and a reappraisal of the calibration belt for the assessment of prediction models based on dichotomous outcomes. Stat Med 33:2390–2407. https://doi.org/10.1002/sim.6100

    Article  PubMed  Google Scholar 

  23. Poole D, Carrara G, Bertolini G (2017) Intensive care medicine in 2050: statistical tools for development of prognostic models (why clinicians should not be ignored). Intensive Care Med 43:1403–1406. https://doi.org/10.1007/s00134-017-4825-x

    Article  PubMed  Google Scholar 

  24. Azoulay E, Mokart D, Pène F et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 31:2810–2818. https://doi.org/10.1200/JCO.2012.47.2365

    Article  PubMed  Google Scholar 

  25. Soares M, Salluh JIF, Carvalho MS et al (2006) Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 24:4003–4010. https://doi.org/10.1200/JCO.2006.05.7869

    Article  PubMed  Google Scholar 

  26. Mokart D, Sannini A, Brun J-P et al (2007) N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shock. Crit Care 11:R37. https://doi.org/10.1186/cc5721

    Article  PubMed  PubMed Central  Google Scholar 

  27. Azoulay E, Mokart D, Rabbat A et al (2008) Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 36:100–107. https://doi.org/10.1097/01.CCM.0000295590.33145.C4

    Article  PubMed  Google Scholar 

  28. McGrath S, Chatterjee F, Whiteley C, Ostermann M (2010) ICU and 6-month outcome of oncology patients in the intensive care unit. QJM 103:397–403. https://doi.org/10.1093/qjmed/hcq032

    Article  CAS  PubMed  Google Scholar 

  29. Legriel S, Marijon H, Darmon M et al (2010) Central neurological complications in critically ill patients with malignancies. Intensive Care Med 36:232–240. https://doi.org/10.1007/s00134-009-1709-8

    Article  PubMed  Google Scholar 

  30. Soares M, Silva UVA, Teles JMM et al (2010) Validation of four prognostic scores in patients with cancer admitted to Brazilian intensive care units: results from a prospective multicenter study. Intensive Care Med 36:1188–1195. https://doi.org/10.1007/s00134-010-1807-7

    Article  PubMed  Google Scholar 

  31. Song J-U, Suh GY, Chung MP et al (2011) Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer 19:491–495. https://doi.org/10.1007/s00520-010-0841-x

    Article  PubMed  Google Scholar 

  32. Bird GT, Farquhar-Smith P, Wigmore T et al (2012) Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth 108:452–459. https://doi.org/10.1093/bja/aer449

    Article  CAS  PubMed  Google Scholar 

  33. Hill QA, Kelly RJ, Patalappa C et al (2012) Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study. Leuk Lymphoma 53:282–288. https://doi.org/10.3109/10428194.2011.614705

    Article  PubMed  Google Scholar 

  34. Xhaard A, Epelboin L, Schnell D et al (2013) Outcomes in critically ill chronic lymphocytic leukemia patients. Support Care Cancer 21:1885–1891. https://doi.org/10.1007/s00520-013-1744-4

    Article  PubMed  Google Scholar 

  35. Namendys-Silva SA, González-Herrera MO, García-Guillén FJ et al (2013) Outcome of critically ill patients with hematological malignancies. Ann Hematol 92:699–705. https://doi.org/10.1007/s00277-013-1675-7

    Article  PubMed  Google Scholar 

  36. Wohlfarth P, Staudinger T, Sperr WR et al (2014) Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol 93:1629–1636. https://doi.org/10.1007/s00277-014-2141-x

    Article  CAS  PubMed  Google Scholar 

  37. Soares M, Salluh JIF, Torres VBL et al (2008) Short- and long-term outcomes of critically ill patients with cancer and prolonged ICU length of stay. Chest 134:520–526. https://doi.org/10.1378/chest.08-0359

    Article  PubMed  Google Scholar 

  38. Depuydt PO, Benoit DD, Roosens CD et al (2010) The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure. J Crit Care 25:30–36. https://doi.org/10.1016/j.jcrc.2009.02.016

    Article  PubMed  Google Scholar 

  39. Canet E, Zafrani L, Lambert J et al (2013) Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS One 8:e55870. https://doi.org/10.1371/journal.pone.0055870

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Müller AM, Gazzana MB, Silva DR (2013) Outcomes for patients with lung cancer admitted to intensive care units. Rev Bras Ter Intensiva 25:12–16

    Article  Google Scholar 

  41. Oeyen SG, Benoit DD, Annemans L et al (2013) Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study. Intensive Care Med 39:889–898. https://doi.org/10.1007/s00134-012-2791-x

    Article  CAS  PubMed  Google Scholar 

  42. Ferrà C, Marcos P, Misis M et al (2007) Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience. Int J Hematol 85:195–202. https://doi.org/10.1532/IJH97.E0625

    Article  PubMed  Google Scholar 

  43. Soares M, Darmon M, Salluh JIF et al (2007) Prognosis of lung cancer patients with life-threatening complications. Chest 131:840–846. https://doi.org/10.1378/chest.06-2244

    Article  PubMed  Google Scholar 

  44. Toffart A-C, Minet C, Raynard B et al (2011) Use of intensive care in patients with nonresectable lung cancer. Chest 139:101–108. https://doi.org/10.1378/chest.09-2863

    Article  PubMed  Google Scholar 

  45. Burghi G, Lemiale V, Seguin A et al (2011) Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis. Intensive Care Med 37:1605–1612. https://doi.org/10.1007/s00134-011-2344-8

    Article  PubMed  Google Scholar 

  46. Adda M, Coquet I, Darmon M et al (2008) Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 36:2766–2772. https://doi.org/10.1097/CCM.0b013e31818699f6

    Article  PubMed  Google Scholar 

  47. Yoo H, Suh GY, Jeong B-H et al (2013) Etiologies, diagnostic strategies, and outcomes of diffuse pulmonary infiltrates causing acute respiratory failure in cancer patients: a retrospective observational study. Crit Care 17:R150. https://doi.org/10.1186/cc12829

    Article  PubMed  PubMed Central  Google Scholar 

  48. Lee D-S, Suh GY, Ryu J-A et al (2015) Effect of early intervention on long-term outcomes of critically ill cancer patients admitted to ICUs. Crit Care Med 43:1439–1448. https://doi.org/10.1097/CCM.0000000000000989

    Article  CAS  PubMed  Google Scholar 

  49. Soares M, Salluh JIF, Toscano L, Dias FL (2007) Outcomes and prognostic factors in patients with head and neck cancer and severe acute illnesses. Intensive Care Med 33:2009–2013. https://doi.org/10.1007/s00134-007-0775-z

    Article  PubMed  Google Scholar 

  50. Souza-Dantas VC, Salluh JIF, Soares M (2011) Impact of neutropenia on the outcomes of critically ill patients with cancer: a matched case-control study. Ann Oncol 22:2094–2100. https://doi.org/10.1093/annonc/mdq711

    Article  CAS  PubMed  Google Scholar 

  51. Soares M, Toffart A-C, Timsit J-F et al (2014) Intensive care in patients with lung cancer: a multinational study. Ann Oncol 25:1829–1835. https://doi.org/10.1093/annonc/mdu234

    Article  CAS  PubMed  Google Scholar 

  52. Mokart D, Etienne A, Esterni B et al (2012) Critically ill cancer patients in the intensive care unit: short-term outcome and 1-year mortality. Acta Anaesthesiol Scand 56:178–189. https://doi.org/10.1111/j.1399-6576.2011.02579.x

    Article  CAS  PubMed  Google Scholar 

  53. Yeo CD, Kim JW, Kim SC et al (2012) Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. J Crit Care 27:739.e1–739.e6. https://doi.org/10.1016/j.jcrc.2012.07.014

    Article  Google Scholar 

  54. Khassawneh BY, White P, Anaissie EJ et al (2002) Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 121:185–188

    Article  Google Scholar 

  55. Townsend WM, Holroyd A, Pearce R et al (2013) Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol 161:578–586. https://doi.org/10.1111/bjh.12294

    Article  PubMed  PubMed Central  Google Scholar 

  56. Zuber B, Tran T-C, Aegerter P et al (2012) Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 40:55–62. https://doi.org/10.1097/CCM.0b013e31822d74ba

    Article  PubMed  Google Scholar 

  57. Benoit DD, Soares M, Azoulay E (2014) Has survival increased in cancer patients admitted to the ICU? We are not sure. Intensive Care Med 40:1576–1579. https://doi.org/10.1007/s00134-014-3480-8

    Article  PubMed  Google Scholar 

  58. Soares M, Bozza FA, Azevedo LCP et al (2016) Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units. J Clin Oncol 34:3315–3324. https://doi.org/10.1200/JCO.2016.66.9549

    Article  PubMed  Google Scholar 

  59. Mokart D, Azoulay E, Schnell D et al (2013) Acute respiratory failure in neutropenic patients is associated with a high post-ICU mortality. Minerva Anestesiol 79:1156–1163

    CAS  PubMed  Google Scholar 

  60. Bagshaw SM, George C, Bellomo R, ANZICS Database Management Committee (2007) Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 11:R68. https://doi.org/10.1186/cc5949

    Article  PubMed  PubMed Central  Google Scholar 

  61. Kaukonen K-M, Bailey M, Pilcher D et al (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372:1629–1638. https://doi.org/10.1056/NEJMoa1415236

    Article  CAS  PubMed  Google Scholar 

  62. Esteban A, Frutos-Vivar F, Muriel A et al (2013) Evolution of mortality over time in patients receiving mechanical ventilation. Am J Respir Crit Care Med 188:220–230. https://doi.org/10.1164/rccm.201212-2169OC

    Article  PubMed  Google Scholar 

  63. Lautrette A, Garrouste-Orgeas M, Bertrand P-M et al (2015) Respective impact of no escalation of treatment, withholding and withdrawal of life-sustaining treatment on ICU patients’ prognosis: a multicenter study of the Outcomerea Research Group. Intensive Care Med 41:1763–1772. https://doi.org/10.1007/s00134-015-3944-5

    Article  PubMed  Google Scholar 

  64. Benoit DD, Jensen HI, Malmgren J et al (2018) Outcome in patients perceived as receiving excessive care across different ethical climates: a prospective study in 68 intensive care units in Europe and the USA. Intensive Care Med 44:1039–1049. https://doi.org/10.1007/s00134-018-5231-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Waikar SS, Curhan GC, Wald R et al (2006) Declining mortality in patients with acute renal failure, 1988 to 2002. JASN 17:1143–1150. https://doi.org/10.1681/ASN.2005091017

    Article  PubMed  Google Scholar 

  66. Xue JL, Daniels F, Star RA et al (2006) Incidence and mortality of acute renal failure in medicare beneficiaries, 1992 to 2001. JASN 17:1135–1142. https://doi.org/10.1681/ASN.2005060668

    Article  PubMed  Google Scholar 

  67. Panageas KS, Schrag D, Riedel E et al (2003) The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med 139:658–665

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Sophie Perinel and Marie Bouteloup for their invaluable help with this study.

Funding

None.

Author information

Authors and Affiliations

  1. Medical ICU, Saint-Louis University Hospital, AP-HP, Paris, France

    Michaël Darmon, Virginie Lemiale & Elie Azoulay

  2. Faculté de Médecine, Université Paris-Diderot, Sorbonne-Paris-Cité, Paris, France

    Michaël Darmon, Aurélie Bourmaud & Elie Azoulay

  3. ECSTRA Team, Biostatistics and Clinical Epidemiology, UMR 1153 (Center of Epidemiology and Biostatistic Sorbonne Paris Cité, CRESS), INSERM, Paris, France

    Michaël Darmon & Elie Azoulay

  4. Public Health Department, Robert Debré University Hospital, AP-HP, Paris, France

    Aurélie Bourmaud

  5. UMRS 1123, Clinical Epidemiology and Economic Evaluation Applied to Vulnerable Populations (Epidémiologie Clinique et Évaluation Économique appliquée aux Populations Vulnérables [ECEVE]), Paris Diderot University, Paris, France

    Aurélie Bourmaud

  6. Medical-Surgical ICU, Saint-Etienne University Hospital, Saint-Étienne, France

    Quentin Georges

  7. Department of Critical Care and Graduate Program in Translational Medicine, D’Or Institute for Research and Education, Rio de Janeiro, Brazil

    Marcio Soares

  8. Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

    Kyeongman Jeon

  9. Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium

    Sandra Oeyen & Pieter Depuydt

  10. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, The Catholic University of Korea, Seoul, South Korea

    Chin Kook Rhee

  11. Department of Critical Care, The Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK

    Pascale Gruber

  12. Department of Critical Care and Nephrology, King’s College London, Guy’s and St Thomas’ NHS Foundation Hospital, London, UK

    Marlies Ostermann

  13. Department of Haematology, Leeds Teaching Hospitals, Leeds, UK

    Quentin A. Hill

  14. Department of Clinical Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain

    Christelle Ferra

  15. Thoracic Oncology Unit, Grenoble Alpes University Hospital, Grenoble, France

    Anne-Claire Toffart

  16. Department of Medicine I, Intensive Care Unit 13i2, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

    Peter Schellongowski

  17. Universidade Federal do Rio Grande do Sul, Rio Grande do Sul, Porto Alegre, Brazil

    Alice Müller

  18. Anesthesiology and Intensive Care Unit, Institut Paoli Calmette, Marseille, France

    Djamel Mokart

Authors
  1. Michaël Darmon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aurélie Bourmaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Quentin Georges
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcio Soares
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kyeongman Jeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sandra Oeyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chin Kook Rhee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pascale Gruber
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marlies Ostermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Quentin A. Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Pieter Depuydt
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Christelle Ferra
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Anne-Claire Toffart
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Peter Schellongowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Alice Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Virginie Lemiale
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Djamel Mokart
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Elie Azoulay
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MD conceived the study, participated in study design and coordination, acquisition of data, statistical analysis and interpretation of data, drafting of the manuscript and critical revision of the manuscript. AB participated in statistical analysis, interpretation of data, drafting of the manuscript and critical revision of the manuscript. QG participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. MS participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. KJ participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. SO participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. CKR participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. PG participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. MO participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. QAH participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. PD participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. CF participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. ACT participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. PS participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. AM participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. VL participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. FT participated in statistical analysis, interpretation of data, drafting of the manuscript and critical revision of the manuscript. DM participated in study design, interpretation of data, and critical revision of the manuscript. EA participated in acquisition of data, interpretation of data, drafting of the manuscript and critical revision of the manuscript. All authors read and approved the final manuscript. MD affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as registered have been explained. MD had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Corresponding author

Correspondence to Michaël Darmon.

Ethics declarations

Conflicts of interest

Dr. Darmon report having received consulting fees from Sanofi and Gilead-Kite, research support from Astute Medical and MSD, and speaker fees from MSD, Gilead-Kite and Astellas. Dr Ostermann received research support from Fresenius Medical and LaJolla Pharma. Dr. Azoulay reports grants, personal fees and other from Gilead-Kite, personal fees from Baxter, personal fees and other from Alexion, grants from MSD, grants from Ablynx, non-financial support from Fisher & payckle, outside the submitted work. Other authors report no conflict of interest related to this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 335 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Darmon, M., Bourmaud, A., Georges, Q. et al. Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med 45, 977–987 (2019). https://doi.org/10.1007/s00134-019-05653-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-019-05653-7

Keywords

Search

Navigation